Thomas Seufferlein discusses diagnostic and treatment options for pancreatic cancer, as well as his thoughts on recent advancements, emerging treatments and trials, such as the TRYbeCA1 study.
Browsing: treatment trends
In this joint interview we delve deeper into the news story to find out both the clinician’s and patient’s perspective on the recent recommendation of ixazomib for NHS distribution.
In this editorial from Future Oncology, discover how oncolytic viruses may be utilized to target and destroy tumor cells in a currently underexplored immunotheraputic approach.
Leiomyosarcoma of the stomach with metastasis to the liver: a case report with review of the literature
In this report the authors discuss diagnosis and treatment of a patient with leiomyosarcoma of the stomach, whose disease progressed 2 years after he was disease-free following initial treatment.
Researchers from the Case Western Reserve University (OH, USA) have demonstrated how a computer program can suggest novel cancer treatments.
In this research article from the Journal of Comparative Effectiveness Research find out about the characteristics and treatment patterns among US patients with hairy cell leukemia.
Research into the PD-L1 pathway has discovered a novel protein known as CMTM6, which binds to PD-L1 on T cell surfaces and enhances PD-L1’s ability to inhibit T cell immune responses. The findings may offer a novel immunotherapy target for many types of cancer.
In this review article, the current knowledge of miRNAs and colorectal cancer diagnosis, prognosis and novel or evolving therapeutic concepts are discussed.
Listen to this exclusive interview with Dirk Arnold from Klinik für Tumorbiologie (Freiburg, Germany) about current treatment options for rectal cancer, how we can define a strategy for oligometastic rectal cancer and his hopes for the future of this field.
Study highlights variation in treatment and survival for individuals with non-small-cell lung cancer
Researchers have demonstrated that individuals with non-small-cell lung cancer who are untreated have a significantly shorter overall survival rate.